1. rlmcdonough
2. emh8473
3. steh3587
4. redoctober30
5. yellow31sleeping
1.emh8473 03/16/2018
What's the price target?
2.emh8473 03/12/2018
Reports positive Phase 1/2 Results of AKCEA-APOCIII-LRx presented at American College of Cardiology Annual S…
3.rlmcdonough 03/15/2018
4.rlmcdonough 03/15/2018
Done? I dont think so
5.rlmcdonough 03/26/2018
Drop today
6.rlmcdonough 02/27/2018
Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017
7.emh8473 03/15/2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
8.redoctober30 07/12/2018
Announces that TEGSEDI has received marketing authorization approval from the European Commission, up 10%
9.steh3587 03/15/2018
Should be Running for a couple days imo
10.rlmcdonough 01/05/2018
Nice! Akcea Initiates Phase 2b Study of AKCEA-APOCIII-LRx in Patients with Hypertriglyceridemia and Established Cardiovascular Disease
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW